GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioGend Therapeutics Co Ltd (ROCO:6733) » Definitions » Price-to-Tangible-Book

BioGend Therapeutics Co (ROCO:6733) Price-to-Tangible-Book : 5.58 (As of May. 27, 2025)


View and export this data going back to 2019. Start your Free Trial

What is BioGend Therapeutics Co Price-to-Tangible-Book?

As of today (2025-05-27), BioGend Therapeutics Co's share price is NT$29.90. BioGend Therapeutics Co's Tangible Book per Share of Mar. 2025 for the quarter that ended in Mar. 2025 was NT$5.36. Hence, BioGend Therapeutics Co's Price to Tangible Book Ratio of today is 5.58.

The historical rank and industry rank for BioGend Therapeutics Co's Price-to-Tangible-Book or its related term are showing as below:

ROCO:6733' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.06   Med: 5.05   Max: 7.17
Current: 5.58

During the past 9 years, BioGend Therapeutics Co's highest Price to Tangible Book Ratio was 7.17. The lowest was 3.06. And the median was 5.05.

ROCO:6733's Price-to-Tangible-Book is ranked worse than
71.69% of 1194 companies
in the Biotechnology industry
Industry Median: 2.715 vs ROCO:6733: 5.58

A closely related ratio is called PB Ratio. As of today, BioGend Therapeutics Co's share price is NT$29.90. BioGend Therapeutics Co's Book Value per Sharefor the quarter that ended in Mar. 2025 was NT$6.33. Hence, BioGend Therapeutics Co's P/B Ratio of today is 4.72.


BioGend Therapeutics Co Price-to-Tangible-Book Historical Data

The historical data trend for BioGend Therapeutics Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGend Therapeutics Co Price-to-Tangible-Book Chart

BioGend Therapeutics Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only 5.87 4.53 4.80 6.09 6.09

BioGend Therapeutics Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.06 6.47 6.46 6.09 5.89

Competitive Comparison of BioGend Therapeutics Co's Price-to-Tangible-Book

For the Biotechnology subindustry, BioGend Therapeutics Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioGend Therapeutics Co's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioGend Therapeutics Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where BioGend Therapeutics Co's Price-to-Tangible-Book falls into.


;
;

BioGend Therapeutics Co Price-to-Tangible-Book Calculation

BioGend Therapeutics Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2025 )
=29.90/5.361
=5.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


BioGend Therapeutics Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of BioGend Therapeutics Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


BioGend Therapeutics Co Business Description

Traded in Other Exchanges
N/A
Address
Yuanqu Street, 4th Floor, Number 3-2, Nangang District, Taipei, TWN, 115
BioGend Therapeutics Co Ltd is a Taiwan-based company involved in the research and development of orthopedic medical equipment and related products and the sale of related products. It is involved in the research and development of innovative cartilage repair technology and products, adipose stem cell extraction technology, and others. Geographically, the company generates a majority of its revenue from Taiwan followed by China and other regions.

BioGend Therapeutics Co Headlines

No Headlines